Personal tools

MCL coexpression mm9:734: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!1.06e-09!29;UBERON:0005057!1.06e-09!29;UBERON:0000153!2.15e-09!43;UBERON:0001048!2.09e-08!134;UBERON:0002370!1.70e-07!23;UBERON:0000974!1.70e-07!23;UBERON:0004807!1.70e-07!23;UBERON:0005058!1.70e-07!23;UBERON:0003351!1.70e-07!23;UBERON:0009113!1.70e-07!23;UBERON:0003295!1.70e-07!23;UBERON:0009722!1.70e-07!23;UBERON:0005562!1.70e-07!23;UBERON:0007690!1.70e-07!23;UBERON:0000065!5.02e-07!41;UBERON:0000077!6.08e-07!35;UBERON:0006562!6.25e-07!24;UBERON:0001557!6.25e-07!24;UBERON:0001042!6.25e-07!24;UBERON:0008814!6.25e-07!24;UBERON:0009145!6.25e-07!24;UBERON:0007811!7.77e-07!36;UBERON:0000072!8.81e-07!27
|ontology_enrichment_uberon=UBERON:0004177!1.06e-09!29;UBERON:0005057!1.06e-09!29;UBERON:0000153!2.15e-09!43;UBERON:0001048!2.09e-08!134;UBERON:0002370!1.70e-07!23;UBERON:0000974!1.70e-07!23;UBERON:0004807!1.70e-07!23;UBERON:0005058!1.70e-07!23;UBERON:0003351!1.70e-07!23;UBERON:0009113!1.70e-07!23;UBERON:0003295!1.70e-07!23;UBERON:0009722!1.70e-07!23;UBERON:0005562!1.70e-07!23;UBERON:0007690!1.70e-07!23;UBERON:0000065!5.02e-07!41;UBERON:0000077!6.08e-07!35;UBERON:0006562!6.25e-07!24;UBERON:0001557!6.25e-07!24;UBERON:0001042!6.25e-07!24;UBERON:0008814!6.25e-07!24;UBERON:0009145!6.25e-07!24;UBERON:0007811!7.77e-07!36;UBERON:0000072!8.81e-07!27
|tfbs_overrepresentation_for_novel_motifs=0.860199,0.352573,0.807108,0.360062,0.200163,0.373426,0.458558,0.392928,0.411053,0.771958,1.071,0.447169,0.124608,2.06188,0.214197,0,1.57859,0.19356,0.113609,0.205418,0.26524,0.145076,2.05901,0.198877,0.304728,0.496413,0.107695,0.392919,0.67135,0.572447,0.989437,0.754912,0.191698,0.646834,1.1554,0.6066,0.541514,1.12869,0.166348,0.143746,0.196807,0.38461,0.307718,0.617704,0.249283,0.349801,1.41649,0.407653,0.104497,0.677281,0.639101,0.522137,0.0747297,0.894161,0.911367,1.20022,0.249055,0.435119,0.101408,0.47505,1.74318,0.531188,0.140453,0.628155,0.487593,0.667546,1.04613,1.3932,0.730718,1.24673,0.281085,0.404236,0.996746,0.944464,1.09617,0.623453,0.0942164,0.567793,0.718494,0.268962,0.129727,0.673009,0.529804,0.119727,0.830765,0.318393,0.0149522,0.271714,1.42647,1.55487,1.11522,0.835661,0.767462,0.205117,0.490417,0.149272,0.777003,0.770215,0.57902,1.30903,0.184103,0.754637,0.87698,0.639679,0.638654,0.3842,0.696857,0.403887,0.273261,0.266818,0.315128,0.878738,0.26996,1.08155,1.12221,0.5687,0.212667,0.953611,0.657356,0.181004,0.949798,0.607824,0.498153,0.566919,1.17594,0.722111,0.466292,0.760818,1.04463,0.59809,0.86025,0.353344,1.01535,0.48999,1.14365,0.0358067,0.329172,0.385921,2.47881,1.92247,1.5231,1.0508,0.509663,0.765172,0.632358,0.385031,0.581788,1.88287,0.331322,1.73501,0.580497,1.72175,0.895708,0.153911,0.489108,0.976367,2.23719,0.637798,0.319291,1.57707,1.1043,0.829923,0.722546,0.313083,0.629147,0.482049,0.18312,0.445669,0.350088
}}
}}

Revision as of 18:49, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr15:34425057..34425102,+p1@Pop1
Mm9::chr15:8059322..8059356,+p1@Nup155
Mm9::chr17:35378730..35378782,+p1@Ddx39b
Mm9::chr19:47165238..47165290,+p1@Pdcd11
Mm9::chr4:129318235..129318295,-p1@Txlna
Mm9::chr4:148000865..148000884,-p1@Tardbp
Mm9::chr4:62069804..62069899,+p1@Prpf4
Mm9::chr6:35127610..35127627,+p1@Nup205
Mm9::chr8:113370670..113370698,-p1@Sf3b3
Mm9::chr8:126473101..126473187,-p1@Nup133


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005487nucleocytoplasmic transporter activity0.000749205781920186
GO:0051028mRNA transport0.00407034741706452
GO:0050658RNA transport0.00407034741706452
GO:0051236establishment of RNA localization0.00407034741706452
GO:0050657nucleic acid transport0.00407034741706452
GO:0006403RNA localization0.00407034741706452
GO:0005643nuclear pore0.00407034741706452
GO:0065002intracellular protein transport across a membrane0.00407034741706452
GO:0015931nucleobase, nucleoside, nucleotide and nucleic acid transport0.00407034741706452
GO:0046930pore complex0.00407034741706452
GO:0044453nuclear membrane part0.00429391984070031
GO:0031965nuclear membrane0.00429391984070031
GO:0044428nuclear part0.00746703842105303
GO:0006913nucleocytoplasmic transport0.00746703842105303
GO:0051169nuclear transport0.00746703842105303
GO:0017056structural constituent of nuclear pore0.00764090439970906
GO:0005635nuclear envelope0.00886461988172955
GO:0005681spliceosome0.0143799144534344
GO:0046540U4/U6 x U5 tri-snRNP complex0.0160755416039761
GO:0008380RNA splicing0.0197360766737931
GO:0051649establishment of cellular localization0.0243803738730018
GO:0051641cellular localization0.0244002357987189
GO:0004526ribonuclease P activity0.0248546207161951
GO:0006397mRNA processing0.0248546207161951
GO:0006406mRNA export from nucleus0.0248546207161951
GO:0030532small nuclear ribonucleoprotein complex0.0248546207161951
GO:0043123positive regulation of I-kappaB kinase/NF-kappaB cascade0.0248546207161951
GO:0004549tRNA-specific ribonuclease activity0.0261400419890448
GO:0016071mRNA metabolic process0.027836696568666
GO:0043122regulation of I-kappaB kinase/NF-kappaB cascade0.0284511320653779
GO:0006405RNA export from nucleus0.0294935597533027
GO:0012505endomembrane system0.0328158581290779
GO:0016891endoribonuclease activity, producing 5'-phosphomonoesters0.0369009904895174
GO:0032991macromolecular complex0.0382548377726184
GO:0016893endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters0.0382548377726184
GO:0051168nuclear export0.0388742433313261
GO:0006396RNA processing0.0398025270092647
GO:0031975envelope0.0437951567695661
GO:0031967organelle envelope0.0437951567695661
GO:0006886intracellular protein transport0.0448957993436601
GO:0016070RNA metabolic process0.0499137677017831



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
nucleate cell1.39e-0716


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}